Wesley Chapel, FL, April 19, 2024 — Mirror Biologics, Inc., a clinical stage biopharmaceutical company announces the appointment of Elizabeth Adkins Czerepak as Chief Financial Officer (CFO) and Vice President of Corporate Development effective April 15, 2024. Ms. Czerepak has served as CFO of several biotechnology companies over the last 13 years. She has also led teams that successfully launched public offerings over this time.…